Literature DB >> 25481618

IgG4-related disease.

Terumi Kamisawa1, Yoh Zen2, Shiv Pillai3, John H Stone4.   

Abstract

IgG4-related disease is a protean condition that mimics many malignant, infectious, and inflammatory disorders. This multi-organ immune-mediated condition links many disorders previously regarded as isolated, single-organ diseases without any known underlying systemic condition. It was recognised as a unified entity only 10 years ago. Histopathology is the key to diagnosis. The three central pathology features of IgG4-related disease are lymphoplasmacytic infiltration, storiform fibrosis, and obliterative phlebitis. The extent of fibrosis is an important determinant of responsiveness to immunosuppressive therapies. IgG4-related disease generally responds to glucocorticoids in its inflammatory stage, but recurrent or refractory cases are common. Important mechanistic insights have been derived from studies of patients treated by B-cell depletion. Greater awareness of this disease is needed to ensure earlier diagnoses, which can prevent severe organ damage, disabling tissue fibrosis, and even death. Identification of specific antigens and T-cell clones that drive the disease will be the first steps to elucidate the pathogenesis of IgG4-related disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25481618     DOI: 10.1016/S0140-6736(14)60720-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  299 in total

1.  Reply: Further Progress in Understanding Fibrosing Mediastinitis.

Authors:  Tobias Peikert; Blair Westerly; Ulrich Specks
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

2.  Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft Recipients.

Authors:  Stanley C Jordan
Journal:  J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 10.121

3.  [Multifocal tumors in a 56-year-old male patient].

Authors:  G Kaissis; M Eiber; V Becker; K Holzapfel; E J Rummeny; R Braren
Journal:  Radiologe       Date:  2015-11       Impact factor: 0.635

4.  Predictors of disease relapse in IgG4-related disease following rituximab.

Authors:  Zachary S Wallace; Hamid Mattoo; Vinay S Mahajan; Maria Kulikova; Leo Lu; Vikram Deshpande; Hyon K Choi; Shiv Pillai; John H Stone
Journal:  Rheumatology (Oxford)       Date:  2016-02-16       Impact factor: 7.580

5.  [Manifestations of autoimmune disorders in otorhinolaryngology : Classical symptoms and diagnostic approach].

Authors:  B Hofauer; A Chaker; K Thürmel; A Knopf
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

6.  Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease.

Authors:  Hang Liu; Cory A Perugino; Musie Ghebremichael; Zachary S Wallace; Sydney B Montesi; John H Stone; Shiv Pillai
Journal:  Arthritis Rheumatol       Date:  2020-02-10       Impact factor: 10.995

7.  IgG4-related midline destructive lesion.

Authors:  Emanuel Della-Torre; Hamid Mattoo; Vinay S Mahajan; Vikram Deshpande; Donald Krause; Philip Song; Shiv Pillai; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-03-20       Impact factor: 19.103

Review 8.  Perirenal capsule and scrotal involvement in immunoglobulin G4-related kidney disease: case-based review.

Authors:  Yoon-Jin Cho; Wun-Yong Jung; Sang-Yoep Lee; Ji-Sun Song; Hee-Jin Park
Journal:  Rheumatol Int       Date:  2018-06-29       Impact factor: 2.631

9.  Idiopathic hypertrophic pachymeningitis as a rare cause of cervical compressive myelopathy.

Authors:  Aya Fukuda; Elizabete Punaro; Fábio Rogério; Luciano de Souza Queiroz; Fabiano Reis
Journal:  J Craniovertebr Junction Spine       Date:  2017 Oct-Dec

10.  Interferon-gamma increased epithelial barrier function via upregulating claudin-7 expression in human submandibular gland duct epithelium.

Authors:  Ayumi Abe; Kenichi Takano; Takashi Kojima; Kazuaki Nomura; Takuya Kakuki; Yakuto Kaneko; Motohisa Yamamoto; Hiroki Takahashi; Tetsuo Himi
Journal:  J Mol Histol       Date:  2016-03-08       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.